We are live on ! Find out more
DMII

Drugs Made In America Acquisition II Corp
DMII

51 hedge funds and large institutions have $343M invested in Drugs Made In America Acquisition II Corp in 2025 Q4 according to their latest regulatory filings, with 51 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

54.51% more ownership

Funds ownership: 0% → 54.51% (+55%)

Holders
51
Holders Change
+51
Holders Change %
–
% of All Funds
0.62%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
51
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
MF
Magnetar Financial
Illinois
+$26.7M
2
GCL
Glazer Capital LLC
New York
+$23.2M
3
FTCM
First Trust Capital Management
Illinois
+$20.4M
4
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
+$19.5M
5
Millennium Management
Millennium Management
New York
+$14.8M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
MF
1
Magnetar Financial
Illinois
$26.7M +$26.7M +2,700,000 New
GCL
2
Glazer Capital LLC
New York
$23.3M +$23.2M +2,349,899 New
FTCM
3
First Trust Capital Management
Illinois
$20.5M +$20.4M +2,068,118 New
Hudson Bay Capital Management
4
Hudson Bay Capital Management
Connecticut
$19.5M +$19.5M +1,969,030 New
Millennium Management
5
Millennium Management
New York
$14.8M +$14.8M +1,500,000 New
PAMP
6
Polar Asset Management Partners
Ontario, Canada
$14.8M +$14.8M +1,500,000 New
TCM
7
Tenor Capital Management
New York
$14.8M +$14.8M +1,500,000 New
HIM
8
HGC Investment Management
Ontario, Canada
$12.2M +$12.2M +1,230,980 New
AA
9
AQR Arbitrage
Connecticut
$11.4M +$11.4M +1,151,400 New
KIM
10
Karpus Investment Management
New York
$11.3M +$11.3M +1,143,625 New
AC
11
Aristeia Capital
Connecticut
$10.9M +$10.9M +1,100,000 New
WAM
12
Wolverine Asset Management
Illinois
$10.5M +$10.5M +1,062,773 New
DKCM
13
Davidson Kempner Capital Management
New York
$9.9M +$9.89M +1,000,000 New
D.E. Shaw & Co
14
D.E. Shaw & Co
New York
$9.9M +$9.89M +1,000,000 New
OAC
15
OMERS Administration Corp
Ontario, Canada
$9.9M +$9.89M +1,000,000 New
Two Sigma Investments
16
Two Sigma Investments
New York
$8.78M +$8.76M +886,544 New
PMAM
17
Picton Mahoney Asset Management
Ontario, Canada
$8.66M +$8.65M +875,000 New
CL
18
CSS LLC
Illinois
$7.98M +$7.97M +806,001 New
HighTower Advisors
19
HighTower Advisors
Illinois
$7.82M +$7.81M +789,614 New
CCM
20
Context Capital Management
California
$7.42M +$7.41M +750,000 New
GCM
21
Ghisallo Capital Management
Massachusetts
$7.42M +$7.41M +750,000 New
MCM
22
Moore Capital Management
New York
$7.42M +$7.41M +750,000 New
RCM
23
Radcliffe Capital Management
Pennsylvania
$5.7M +$5.69M +575,607 New
WCMNY
24
Westchester Capital Management (New York)
New York
$4.95M +$4.94M +500,000 New
HI
25
HBK Investments
Texas
$4.95M +$4.94M +500,000 New
1
2 3

DMII Hedge Fund Activity: Q4 2025 in Review

51 of the 8,256 institutional investors tracked by Wall St. Rank reported a position in Drugs Made In America Acquisition II Corp (DMII) for Q4 2025, worth a combined $343M.

Buyers outnumbered sellers: 51 funds opened new DMII positions and 0 closed out — a net gain of 51 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Magnetar Financial, opening a new position worth an estimated $26.7M.

  • 51 institutional investors held Drugs Made In America Acquisition II Corp (DMII) as of Q4 2025, up from 0 in Q3 2025.
  • Funds reported $343M of Drugs Made In America Acquisition II Corp stock for Q4 2025.
  • 51 funds opened new Drugs Made In America Acquisition II Corp positions in Q4 2025 and 0 closed out, a net change of +51 holders.
  • The largest Drugs Made In America Acquisition II Corp buyer in Q4 2025 was Magnetar Financial, an estimated $26.7M added.

Based on aggregated 13F filings for Q4 2025.